Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Chronic Respiratory Disease
|
March 2, 2018
Vitamin D<sub>3</sub> supplementation in adults with bronchiectasis: A pilot study
Jim Bartley, Jeff Garrett, Carlos A Camargo, et al.
Frontiers in Public Health
|
November 3, 2022
Measurable outcomes of consumer engagement in health research: A scoping review
Emily DeBortoli, H Peter Soyer, David Milne, et al.
Lancet (London, England)
|
August 21, 2012
Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
Conroy Wong, Lata Jayaram, Noel Karalus, et al.
Psychological Medicine
|
July 7, 2020
Preventing depression using a smartphone app: a randomized controlled trial
Mark Deady, Nicholas Glozier, Rafael Calvo, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 4, 2011
Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis
Chris De Savi, Andrew Pape, Yvonne Sawyer, et al.
BMJ Open
|
July 16, 2018
Smartphone application for preventing depression: study protocol for a workplace randomised controlled trial
Mark Deady, David A Johnston, Nick Glozier, et al.
European Journal of Human Genetics : EJHG
|
April 17, 2025
Empowering human research ethics committees to review genomics applications: evaluating the utility of a custom online education resource
Ella McGahan, Jennifer Berkman, David Milne, et al.
The European Respiratory Journal
|
November 19, 2021
Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial
Lata Jayaram, Alain C Vandal, Catherina L Chang, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 9, 2011
The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis
Chris De Savi, Andrew Pape, John G Cumming, et al.
Respirology (Carlton, Vic.)
|
October 28, 2024
Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand
Hayley Barnes, Tamera J Corte, Gregory Keir, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Chronic Respiratory Disease
|
March 2, 2018
Vitamin D<sub>3</sub> supplementation in adults with bronchiectasis: A pilot study
Jim Bartley, Jeff Garrett, Carlos A Camargo, et al.
Frontiers in Public Health
|
November 3, 2022
Measurable outcomes of consumer engagement in health research: A scoping review
Emily DeBortoli, H Peter Soyer, David Milne, et al.
Lancet (London, England)
|
August 21, 2012
Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
Conroy Wong, Lata Jayaram, Noel Karalus, et al.
Psychological Medicine
|
July 7, 2020
Preventing depression using a smartphone app: a randomized controlled trial
Mark Deady, Nicholas Glozier, Rafael Calvo, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 4, 2011
Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis
Chris De Savi, Andrew Pape, Yvonne Sawyer, et al.
BMJ Open
|
July 16, 2018
Smartphone application for preventing depression: study protocol for a workplace randomised controlled trial
Mark Deady, David A Johnston, Nick Glozier, et al.
European Journal of Human Genetics : EJHG
|
April 17, 2025
Empowering human research ethics committees to review genomics applications: evaluating the utility of a custom online education resource
Ella McGahan, Jennifer Berkman, David Milne, et al.
The European Respiratory Journal
|
November 19, 2021
Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial
Lata Jayaram, Alain C Vandal, Catherina L Chang, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 9, 2011
The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis
Chris De Savi, Andrew Pape, John G Cumming, et al.
Respirology (Carlton, Vic.)
|
October 28, 2024
Diagnosis and management of hypersensitivity pneumonitis in adults: A position statement from the Thoracic Society of Australia and New Zealand
Hayley Barnes, Tamera J Corte, Gregory Keir, et al.
Page
of 5